Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605570 | Apparatus and method for ultrasound spinal cord stimulation | 🖼🧊📄§ | 2026-04-21 | 2044-11-26 | 0 | 31 |
| 12606608 | Modified NK-92 cells, and therapeutic and diagnostic uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-09 | 0 | 31 |
| 12605539 | Methods and systems for delivering drugs through skin of a body | 🖼🧊📄§ | 2026-04-21 | 2040-06-24 | 0 | 31 |
| 12606637 | Heparanase-neutralizing A54 monoclonal antibody | 🖼🧊📄§ | 2026-04-21 | 2041-07-06 | 0 | 31 |
| 12605444 | Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same | 🖼🧊📄§ | 2026-04-21 | 2041-01-08 | 0 | 31 |
| 12605438 | SARS-CoV-2 vaccines and antibodies | 🖼🧊📄§ | 2026-04-21 | 2043-03-02 | 0 | 31 |
| 12605389 | PI3K-δ inhibitor for use in treatment regimens | 🖼🧊📄§ | 2026-04-21 | 2042-03-29 | 0 | 31 |
| 12605426 | Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof | 🖼🧊📄§ | 2026-04-21 | 2041-02-15 | 0 | 31 |
| 12605317 | Water-in-oil makeup cosmetic composition having water resistance and cleansing properties | 🖼🧊📄§ | 2026-04-21 | 2042-01-19 | 0 | 31 |
| 12605373 | Methods and compositions of inhibiting DCN1-UBC12 interaction | 🖼🧊📄§ | 2026-04-21 | 2044-03-05 | 0 | 31 |
| 12605400 | Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment | 🖼🧊📄§ | 2026-04-21 | 2040-04-29 | 0 | 31 |
| 12605330 | Screening method for offensive odor-suppressing material | 🖼🧊📄§ | 2026-04-21 | 2040-10-30 | 0 | 31 |
| 12605418 | Chebulinic acid and its enriched fraction from the fruits of Terminalia chebula for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-09-13 | 0 | 31 |
| 12605325 | Hair styling compositions for improving the elongation of hair curls | 🖼🧊📄§ | 2026-04-21 | 2040-06-30 | 0 | 31 |
| 12605350 | Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component | 🖼🧊📄§ | 2026-04-21 | 2041-06-30 | 0 | 31 |
| 12605358 | Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-02-16 | 0 | 31 |
| 12605337 | Nanoparticle drug targeting JFK and use thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605345 | Transdermal drug delivery system | 🖼🧊📄§ | 2026-04-21 | 2043-12-01 | 0 | 31 |
| 12606829 | Compositions for herpesvirus transcriptional feedback circuit disruption and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2039-06-12 | 0 | 31 |
| 12606533 | 3-phenylpropylamine derivative | 🖼🧊📄§ | 2026-04-21 | 2045-04-11 | 0 | 31 |
| 12606621 | Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer | 🖼🧊📄§ | 2026-04-21 | 2042-10-20 | 0 | 31 |
| 12606520 | Calpain-2 inhibitor compounds and methods of treatment | 🖼🧊📄§ | 2026-04-21 | 2041-02-12 | 0 | 31 |
| 12606834 | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials | 🖼🧊📄§ | 2026-04-21 | 2041-09-10 | 0 | 31 |
| 12605460 | Stem cell-nano drug delivery system complex, use thereof and method for preparing the same | 🖼🧊📄§ | 2026-04-21 | 2044-06-21 | 0 | 31 |
| 12606521 | Methods of treating cancer | 🖼🧊📄§ | 2026-04-21 | 2041-08-30 | 0 | 31 |
| 12606604 | Therapeutic compounds and methods | 🖼🧊📄§ | 2026-04-21 | 2041-08-06 | 0 | 31 |
| 12606555 | Chemical compounds | 🖼🧊📄§ | 2026-04-21 | 2042-04-07 | 0 | 31 |
| 12605379 | Methods of improving lung function | 🖼🧊📄§ | 2026-04-21 | 2045-09-12 | 0 | 31 |
| 12606595 | Regentide-041 and composition comprising Regentide-041 for improving skin condition | 🖼🧊📄§ | 2026-04-21 | 2041-06-08 | 0 | 31 |
| 12606635 | Glypican-2-binding moieties, chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12606623 | DLL3 targeting chimeric antigen receptors and binding agents | 🖼🧊📄§ | 2026-04-21 | 2043-04-27 | 0 | 31 |
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12606553 | Crystalline forms, compositions containing same, and methods of their use | 🖼🧊📄§ | 2026-04-21 | 2042-03-09 | 0 | 31 |
| 12605443 | SAR-CoV-2 DNA vaccine and method of administering thereof | 🖼🧊📄§ | 2026-04-21 | 2041-10-13 | 0 | 31 |
| 12605395 | Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605445 | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 🖼🧊📄§ | 2026-04-21 | 2044-01-12 | 0 | 31 |
| 12605399 | Compositions for CFTR MRNA therapy | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12605321 | Personal care compositions | 🖼🧊📄§ | 2026-04-21 | 2041-03-29 | 0 | 31 |
| 12606779 | Active agent-containing articles | 🖼🧊📄§ | 2026-04-21 | 2043-08-28 | 0 | 31 |
| 12605710 | Flow channel structure for removing foreign substance, method for removing foreign substance, and method for manufacturing lipid particles | 🖼🧊📄§ | 2026-04-21 | 2043-03-13 | 0 | 31 |
| 12605441 | Immunogenic trimers | 🖼🧊📄§ | 2026-04-21 | 2044-06-04 | 0 | 31 |
| 12605452 | Compounds that degrade kinases and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-03 | 0 | 31 |
| 12606875 | Fish Totivirus | 🖼🧊📄§ | 2026-04-21 | 2040-02-04 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605331 | Composition comprising iris-derived exosome as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2043-12-27 | 0 | 31 |
| 12605334 | Method of enhancing the efficacy and stability of ingredients in suspensions | 🖼🧊📄§ | 2026-04-21 | 2043-12-04 | 0 | 31 |
| 12605402 | Therapeutic uses of oxidizing hypotonic acid solutions | 🖼🧊📄§ | 2026-04-21 | 2040-07-02 | 0 | 31 |
| 12606709 | Method for increasing specific surface area of titanium phosphate plate-shaped particles, and powder containing plate-shaped particles derived from titanium phosphate | 🖼🧊📄§ | 2026-04-21 | 2040-05-15 | 0 | 31 |
| 12605239 | Enhancement of hydration and improvement in gut health through cloacal delivery of products | 🖼🧊📄§ | 2026-04-21 | 2041-07-29 | 0 | 31 |
| 12605365 | Losartan liquid formulations and methods of use | 🖼🧊📄§ | 2026-04-21 | 2042-12-05 | 0 | 31 |